CLOV vs EXFY · rev $1.37B vs rev $139.2M
Clover Health Investments Corp (CLOV) versus Expensify Inc (EXFY) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Expensify Inc (EXFY) is a software - application company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported EXFY revenue for 2024-12-31 was $139.2M. Net income was -$10.1M. Revenue was down 7.6% from 2023-12-31 to 2024-12-31. EXFY currently screens at market cap $124.9M.
CLOV currently screens at market cap $1.55B. EXFY currently screens at market cap $124.9M.
Not investment advice. Open the CLOV and EXFY stock pages for the full models.
Not investment advice.